scholarly article | Q13442814 |
P2093 | author name string | Howatson AG | |
Carter DC | |||
P2860 | cites work | A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid | Q26778512 |
A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine | Q28331427 | ||
Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices | Q33951666 | ||
Islet cells as a component of pancreatic ductal neoplasms. I. Experimental study: ductular cells, including islet cell precursors, as primary progenitor cells of tumors | Q36058406 | ||
Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture | Q39991517 | ||
Recent developments in the measurement of nucleic acids in biological materials. A supplementary review | Q40031065 | ||
Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats | Q40864402 | ||
Methylated purines in the deoxyribonucleic acid of various Syrian-golden-hamster tissues after administration of a hepatocarcinogenic dose of dimethylnitrosamine | Q42535582 | ||
An epidemiological evaluation of the causes of cancer of the pancreas | Q50155960 | ||
N'-nitrosonornicotine in tobacco. | Q54263979 | ||
Possible Synthesis of Polyribonucleotides of Known Base-triplet Sequences | Q58970965 | ||
Cancer mortality among chemists | Q64916803 | ||
The properties of O 6 -methylguanine in templates for RNA polymerase | Q69521209 | ||
Chemical carcinogenesis | Q69955579 | ||
Activation of nitrosamines to mutagens by postmitochondrial fraction of hamster pancreas | Q71127549 | ||
Electron microscopic autoradiography of the pancreas in the hamster treated with tritiated N-nitroso-2,6-dimethylmorpholine | Q72139488 | ||
Cohort study of workers exposed to betanaphthylamine and benzidine | Q72223303 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | carcinogenesis | Q1637543 |
cholecystokinin | Q60315441 | ||
P304 | page(s) | 107-114 | |
P577 | publication date | 1985-01-01 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model | |
P478 | volume | 51 |
Q34343379 | A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). |
Q37975722 | Aetiology of pancreatic cancer |
Q44946442 | Are energy and energy-providing nutrients related to exocrine carcinoma of the pancreas? |
Q43607852 | Aspects of medical history and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands |
Q34533173 | Augmentation of chemically induced pancreatic and bronchial cancers by epidermal growth factor |
Q41614766 | Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin |
Q41859754 | Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer |
Q34394264 | Biology of pancreatic cancer |
Q41694806 | CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium |
Q68516308 | Cancer of the pancreas |
Q81349587 | Carcinoid syndrome misdiagnosed as a malabsorptive syndrome after biliopancreatic diversion |
Q37370473 | Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma |
Q33816883 | Cholecystokinin and pancreatic cancer: the chicken or the egg? |
Q36071597 | Cholecystokinin antagonists--a toxicologic perspective |
Q33894658 | Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat. |
Q50085980 | Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice |
Q34167464 | Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice |
Q41207409 | Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines |
Q68581002 | Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990 |
Q78158063 | Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer |
Q41525783 | Comparative effects of neurotensin and neuromedin N on growth of human pancreatic cancer, MIA PaCa-2. |
Q36620579 | Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer |
Q37352570 | Diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands |
Q72969104 | Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters |
Q34533241 | Effect of experimental pancreatic growth on the content of xenobiotic-metabolising enzymes in the pancreas |
Q41731843 | Effects of a high-fat diet and L364,718 on growth of human pancreas cancer |
Q77619819 | Effects of cholecystokinin octapeptide on a pancreatic acinar carcinoma in the rat |
Q41660160 | Effects of cholecystokinin on cytosolic calcium in human pancreatic cancer cells |
Q53447303 | Effects of high-fat diet and cholecystokinin receptor blockade on promotion of pancreatic ductal cell tumors in the hamster. |
Q44067981 | Effects of long term feeding of raw soya bean flour on virus-induced pancreatic carcinogenesis in guinea fowl |
Q70879336 | Enhancement of biliary carcinogenesis in hamsters by cholecystokinin |
Q39744559 | Food and cancer: cause and effect? |
Q77750257 | Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma |
Q40712629 | Hormonal therapy of pancreatic carcinoma. Rationale and perspectives. |
Q43721752 | Increased incidence of pancreatic neoplasia in pernicious anemia |
Q39255670 | Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents |
Q68325503 | Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide |
Q41827161 | Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion |
Q39685995 | Interface between adaptive and neoplastic growth in the pancreas |
Q38041420 | Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents |
Q53479476 | Kinetic changes and experimental carcinogenesis after Billroth I and II gastrectomy. |
Q56780047 | Life-time history of smoking and exocrine carcinoma of the pancreas: A population-based case-control study in the Netherlands |
Q41936517 | Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice |
Q40452708 | On the role of cholecystokinin in pancreatic cancer. |
Q35631058 | PPARalpha agonist-induced rodent tumors: modes of action and human relevance |
Q35613016 | Pancreatic cancer - a continuing challenge in oncology |
Q53440833 | Pancreatic cancer in rats and hamsters does not induce IAPP-related hyperglycaemia. |
Q28372029 | Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers |
Q35645684 | Pancreatic cancer: the role of cholecystokinin? |
Q34604661 | Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines |
Q33841242 | Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin |
Q41154883 | Proliferative response of different exocrine pancreatic cells after surgical pancreaticobiliary diversion in the rat. |
Q69370107 | Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement |
Q43514547 | Risk factors for pancreatic cancer: a case-control study based on direct interviews |
Q35365557 | Risk of pancreatic cancer after cholecystectomy: a cohort study in Sweden |
Q35564914 | Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues |
Q35994163 | Somatostatin binding in normal and malignant human gastrointestinal mucosa |
Q44213678 | Structural changes of the exocrine pancreas in a patient with cholecystolithiasis |
Q36852664 | The activation of beta-substituted nitrosamines that are carcinogenic to the pancreas. |
Q40548301 | The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth |
Q57704454 | Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma |
Search more.